בקשת ציטוטים

Citação APA (7ª ed.)
Aygen, B., Demirtürk, N., Yıldız, O., Çelen, M. K., Çelik, İ., Barut, Ş., . . . Diseases*, T. S. G. f. V. H. o. t. T. S. o. C. M. a. I. (2020). Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience. Turkish Society of Gastroenterology.
Citação do estilo Chicago (17ª ed.)
Aygen, Bilgehan, et al. Real-world Efficacy, Safety, and Clinical Outcomes of Ombitasvir/paritaprevir/ritonavir ± Dasabuvir ± Ribavirin Combination Therapy in Patients with Hepatitis C Virus Genotype 1 or 4 Infection: The Turkey Experience Experience. Turkish Society of Gastroenterology, 2020.
Citação MLA (9ª ed.)
Aygen, Bilgehan, et al. Real-world Efficacy, Safety, and Clinical Outcomes of Ombitasvir/paritaprevir/ritonavir ± Dasabuvir ± Ribavirin Combination Therapy in Patients with Hepatitis C Virus Genotype 1 or 4 Infection: The Turkey Experience Experience. Turkish Society of Gastroenterology, 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.